{
    "organizations": [],
    "uuid": "741d0050f3d73d5d8b295b9d7db123f39bbd1405",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pluristem-reports-as-of-march-31-c/brief-pluristem-reports-as-of-march-31-co-had-34-1-mln-in-cash-and-cash-equivalents-idUSFWN1SH0QM",
    "ord_in_thread": 0,
    "title": "BRIEF-Pluristem Reports As Of March 31, Co Had $34.1 Mln In Cash And Cash Equivalents",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10, 2018 / 11:18 AM / in 4 minutes BRIEF-Pluristem Reports As Of March 31, Co Had $34.1 Mln In Cash And Cash Equivalents Reuters Staff\nMay 10 (Reuters) - Pluristem Therapeutics Inc:\n* PLURISTEM REPORTS THIRD QUARTER FISCAL 2018 CORPORATE AND FINANCIAL HIGHLIGHTS\n* PLURISTEM THERAPEUTICS INC - AS OF MARCH 31, 2018, PLURISTEM HAD $34.1 MILLION IN CASH AND CASH EQUIVALENTS, BANK DEPOSITS AND SHORT-TERM RESTRICTED DEPOSITS Source text for Eikon: Further company coverage:",
    "published": "2018-05-10T14:16:00.000+03:00",
    "crawled": "2018-05-10T14:36:14.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "report",
        "march",
        "co",
        "mln",
        "cash",
        "cash",
        "equivalent",
        "reuters",
        "staff",
        "may",
        "reuters",
        "pluristem",
        "therapeutic",
        "inc",
        "pluristem",
        "report",
        "third",
        "quarter",
        "fiscal",
        "corporate",
        "financial",
        "highlight",
        "pluristem",
        "therapeutic",
        "inc",
        "march",
        "pluristem",
        "million",
        "cash",
        "cash",
        "equivalent",
        "bank",
        "deposit",
        "restricted",
        "deposit",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}